Sulfonamide compounds for the treatment of neurodegenerative...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S238200, C514S311000, C514S361000, C514S364000, C514S374000, C514S381000, C514S522000, C514S539000, C514S604000

Reexamination Certificate

active

11539219

ABSTRACT:
The present invention relates to compounds of the Formula Iwherein R1, R2, R3, m, and n are as defined. Compounds of the Formula I have activity inhibiting production of Aβ-peptide. The invention also relates to pharmaceutical compositions and methods for treating disorders and diseases, for example, neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal comprising compounds of the Formula I.

REFERENCES:
patent: 5491170 (1996-02-01), Lee et al.
patent: 0606046 (1993-12-01), None
patent: 0967201 (1999-12-01), None
patent: 48004784 (1973-02-01), None
patent: WO 9620689 (1996-07-01), None
patent: WO 03051825 (2003-06-01), None
patent: WO 03053912 (2003-07-01), None
Wiley et al, J. Am. Chem. Soc., 1952, 74, 936-938.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfonamide compounds for the treatment of neurodegenerative... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonamide compounds for the treatment of neurodegenerative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide compounds for the treatment of neurodegenerative... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3953810

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.